These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 38759843)

  • 1. Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights.
    Rauth S; Malafa M; Ponnusamy MP; Batra SK
    Gastroenterology; 2024 Oct; 167(5):867-884. PubMed ID: 38759843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention.
    Lyu Y; Xie F; Chen B; Shin WS; Chen W; He Y; Leung KT; Tse GMK; Yu J; To KF; Kang W
    Oncogene; 2024 Jan; 43(2):77-91. PubMed ID: 38081962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
    Yan L; Tan Y; Chen G; Fan J; Zhang J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.
    Correnti M; Binatti E; Gammella E; Invernizzi P; Recalcati S
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
    Jin HR; Wang J; Wang ZJ; Xi MJ; Xia BH; Deng K; Yang JL
    J Hematol Oncol; 2023 Sep; 16(1):103. PubMed ID: 37700339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal Regulation of Cancer-Associated Fibroblasts and Tumor Microenvironment in Gastrointestinal Cancer: Implications for Cancer Dormancy.
    Cheng SH; Chiou HC; Wang JW; Lin MH
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of immune metabolism in skin cancers: implications for pathogenesis and therapy.
    Lu X; Zhu Y; Qin T; Shen Y
    Transl Cancer Res; 2024 Jul; 13(7):3898-3903. PubMed ID: 39145080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant RNA m
    Shen LT; Che LR; He Z; Lu Q; Chen DF; Qin ZY; Wang B
    Cell Death Dis; 2023 Apr; 14(4):236. PubMed ID: 37015927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Roles of the Nervous System in Gastrointestinal Cancer Development.
    Wan C; Yan X; Hu B; Zhang X
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion.
    Lucarini V; Nardozi D; Angiolini V; Benvenuto M; Focaccetti C; Carrano R; Besharat ZM; Bei R; Masuelli L
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment signaling and therapeutics in cancer progression.
    Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
    Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine.
    Piroozkhah M; Gholinezhad Y; Piroozkhah M; Shams E; Nazemalhosseini-Mojarad E
    Front Immunol; 2023; 14():1298891. PubMed ID: 38077386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the intricacies of cancer-associated fibroblasts: a comprehensive review on metabolic reprogramming and tumor microenvironment crosstalk.
    Ahuja S; Sureka N; Zaheer S
    APMIS; 2024 Jun; ():. PubMed ID: 38873945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.
    Liu Y; Zhao Y; Song H; Li Y; Liu Z; Ye Z; Zhao J; Wu Y; Tang J; Yao M
    Cancer Lett; 2024 Aug; 597():217076. PubMed ID: 38906524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster.
    Mishra AK; Singh SK; Dayanandan S; Banerjee S; Chakraborty S; Gopal AB; Samal S; Poirah I; Chakraborty D; Bhattacharyya A
    Cytokine; 2022 Aug; 156():155917. PubMed ID: 35660715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
    Al-Bzour NN; Al-Bzour AN; Ababneh OE; Al-Jezawi MM; Saeed A; Saeed A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly.
    Chu YD; Chen CW; Lai MW; Lim SN; Lin WR
    World J Gastroenterol; 2023 Aug; 29(29):4499-4527. PubMed ID: 37621758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the immune milieu in gastrointestinal cancers.
    Turkes F; Mencel J; Starling N
    J Gastroenterol; 2020 Oct; 55(10):909-926. PubMed ID: 32748171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
    Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.